Parkinson’s Disease (PD), MSA, and DLB are referred to as synucleinopathies resulting from abnormal deposition of α-synuclein in brain cells, while PSP and CBD are referred to as tauopathies resulting from abnormal deposition of tau protein [2]. This evidence concerns the gene MAPT and Parkinson disease.